Actively Recruiting
Evaluation of the Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older
Led by Sultan 1. Murat State Hospital · Updated on 2026-03-23
450
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying neuropathic pain in people aged 80 years and older to understand how common it is and how it relates to various health and daily living factors assessed through a comprehensive geriatric evaluation. The study is observational and aims to explore the connection between neuropathic pain and aspects like mood, nutrition, frailty, and cognitive function in older adults. Participants will undergo a detailed geriatric assessment including recording demographic information, medical history, and recent laboratory results such as thyroid hormone, vitamin levels, blood sugar control, and kidney function. Neuropathic pain will be evaluated using the Douleur Neuropathique-4 (DN4) questionnaire, and pain severity will be measured with the Visual Analog Scale (VAS). The study will also assess mood, daily living activities, cognitive status, frailty, and nutrition during an outpatient clinic visit. During the study, researchers will collect information on participants' pain presence and intensity, mood, ability to perform daily tasks, cognitive function, frailty, and nutritional status. Medication use related to pain will also be recorded. The main outcome is whether neuropathic pain is present at baseline. Participants' health and assessment data will be monitored at this initial visit, providing insights into the relationship between neuropathic pain and geriatric health parameters.
CONDITIONS
Brief Title
Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 80 years or older
- Full cooperation
- Complete comprehensive geriatric assessment parameters
You will not qualify if you...
- Patients with dementia classified as CDR-2 or CDR-3 according to the Clinical Dementia Rating (CDR) Scale
- Patients who have experienced an acute illness within the last 1 month (e.g., infection, fracture, or cerebrovascular disease)
- Patients with a psychotic disorder
- Patients with severe hearing loss
- Patients with a history of malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single baseline assessment
Participants undergo a detailed geriatric assessment including demographic, clinical, and laboratory data collection. Neuropathic pain is assessed using the DN4 questionnaire, and pain intensity, mood, cognitive function, daily activities, frailty, and nutritional status are evaluated.
1 visit (in-person)
Duration - Up to study completion in June 2026
Participants are observed to evaluate the relationship between neuropathic pain and geriatric parameters without active intervention.
No scheduled visits; assessments based on routine care
Trial Site Locations
Total: 1 location
1
Sultan 1. Murat State Hospital
Edirne, Turkey (Türkiye), 22030
Actively Recruiting
Research Team
A
Alper Mengi, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here